Procept Biorobotics Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Procept Biorobotics Corp 公司

PROCEPT BioRobotics Corporation 是一家商業階段的手術機器人公司。該公司致力於通過開發泌尿外科的變革性解決方案來推進患者護理。該公司開發、製造和銷售 AQUABEAM 機器人系統，這是一種先進的圖像引導手術機器人系統，用於微創泌尿外科手術，最初專注於治療良性前列腺增生 (BPH)。該公司專有的 AQUABEAM 機器人系統提供水消融療法，該療法結合了實時、多維成像、個性化治療計劃、自動化機器人和無熱水射流消融，可有針對性地快速去除前列腺組織。水消融療法可爲因 BPH 而患有下尿路症狀 (LUTS) 的男性提供有效、安全和持久的治療效果，且與前列腺的大小和形狀或外科醫生的經驗無關。

公司簡介

公司代碼PRCT

公司名稱Procept Biorobotics Corp

上市日期Sep 15, 2021

成立日期2021

CEODr. Reza Zadno, Ph.D.

員工數量756

證券類型Ordinary Share

年結日Sep 15

公司地址150 Baytech Drive

城市SAN JOSE

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編95134

電話16502329832

網址https://www.procept-biorobotics.com/

公司代碼PRCT

上市日期Sep 15, 2021

成立日期2021

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Frederic H. (Fred) Moll, M.D.

Independent Director

843.16K

+0.18%

Mr. Taylor C. Harris

Independent Director

134.25K

+1.16%

Mr. Kevin Waters

Executive Vice President, Chief Financial Officer

66.61K

-6.22%

Dr. Reza Zadno, Ph.D.

President, Chief Executive Officer, Director

65.97K

+26.35%

Mr. Hisham Shiblaq

Executive Vice President, Chief Commercial Officer

18.05K

--

Ms. Mary Garrett

Independent Director

14.38K

+11.97%

Ms. Elisabeth Little

Independent Director

11.02K

--

Mr. Larry L. Wood

Independent Director

5.97K

+34.72%

Thomas M. Prescott

Independent Chairman of the Board

3.90K

+65.22%

Ms. Alaleh Azarkhish Nouri

Executive Vice President, Chief Legal Officer, Corporate Secretary

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Frederic H. (Fred) Moll, M.D.

Independent Director

843.16K

+0.18%

Mr. Taylor C. Harris

Independent Director

134.25K

+1.16%

Mr. Kevin Waters

Executive Vice President, Chief Financial Officer

66.61K

-6.22%

Dr. Reza Zadno, Ph.D.

President, Chief Executive Officer, Director

65.97K

+26.35%

Mr. Hisham Shiblaq

Executive Vice President, Chief Commercial Officer

18.05K

--

Ms. Mary Garrett

Independent Director

14.38K

+11.97%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Hand pieces and other consumables

42.49M

61.43%

System sales and rentals

22.54M

32.59%

Service

4.13M

5.98%

地區USD

名稱

營收

佔比

United States

60.29M

87.18%

Outside United States

8.87M

12.82%

業務

地區

業務USD

名稱

營收

佔比

Hand pieces and other consumables

42.49M

61.43%

System sales and rentals

22.54M

32.59%

Service

4.13M

5.98%

股東統計

更新時間: 6月8日週日

持股股東

股東類型

持股股東

佔比

Fidelity Management & Research Company LLC

14.67%

The Vanguard Group, Inc.

9.25%

BlackRock Institutional Trust Company, N.A.

6.24%

AllianceBernstein L.P.

3.87%

T. Rowe Price Investment Management, Inc.

2.56%

Other

63.41%

持股股東

佔比

Fidelity Management & Research Company LLC

14.67%

The Vanguard Group, Inc.

9.25%

BlackRock Institutional Trust Company, N.A.

6.24%

AllianceBernstein L.P.

3.87%

T. Rowe Price Investment Management, Inc.

2.56%

Other

63.41%

股東類型

持股股東

佔比

Investment Advisor

45.36%

Investment Advisor/Hedge Fund

34.67%

Hedge Fund

7.57%

Individual Investor

4.25%

Research Firm

3.31%

Bank and Trust

1.10%

Pension Fund

0.73%

Venture Capital

0.66%

Family Office

0.08%

Other

2.26%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

528

53.99M

97.59%

-2.22M

2025Q1

539

53.99M

97.68%

-2.82M

2024Q4

499

53.70M

99.42%

+875.53K

2024Q3

449

49.13M

94.16%

-1.41M

2024Q2

393

47.17M

91.61%

-2.29M

2024Q1

345

48.36M

95.04%

-4.45M

2023Q4

326

47.80M

94.81%

-4.63M

2023Q3

322

46.77M

93.30%

+2.15M

2023Q2

298

38.23M

84.44%

-1.74M

2023Q1

275

35.37M

78.88%

-3.41M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Fidelity Management & Research Company LLC

8.12M

14.67%

+55.63K

+0.69%

Mar 31, 2025

The Vanguard Group, Inc.

5.12M

9.25%

-14.09K

-0.27%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.45M

6.24%

-11.08K

-0.32%

Mar 31, 2025

AllianceBernstein L.P.

2.14M

3.87%

+391.21K

+22.32%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

1.42M

2.56%

+429.46K

+43.56%

Mar 31, 2025

State Street Global Advisors (US)

1.19M

2.15%

-1.44K

-0.12%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.18M

2.14%

+19.63K

+1.69%

Mar 31, 2025

Loomis, Sayles & Company, L.P.

1.18M

2.14%

-25.76K

-2.13%

Mar 31, 2025

T. Rowe Price Associates, Inc.

1.01M

1.83%

+334.20K

+49.20%

Mar 31, 2025

Wellington Management Company, LLP

962.24K

1.74%

-528.72K

-35.46%

Mar 31, 2025

持股ETF

更新時間: 7月6日週日

機構名稱

佔比

Global X HealthTech ETF

3.11%

SPDR S&P Health Care Equipment ETF

1.67%

Global X Robotics & Artificial Intelligence ETF

1.37%

Harbor Health Care ETF

1.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

1.17%

ALPS Disruptive Technologies ETF

0.95%

Langar Global HealthTech ETF

0.86%

Main Thematic Innovation ETF

0.5%

BNY Mellon Innovators ETF

0.43%

Nuveen ESG Small-Cap ETF

0.37%

Global X HealthTech ETF

佔比3.11%

SPDR S&P Health Care Equipment ETF

佔比1.67%

Global X Robotics & Artificial Intelligence ETF

佔比1.37%

Harbor Health Care ETF

佔比1.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比1.17%

ALPS Disruptive Technologies ETF

佔比0.95%

Langar Global HealthTech ETF

佔比0.86%

Main Thematic Innovation ETF

佔比0.5%

BNY Mellon Innovators ETF

佔比0.43%

Nuveen ESG Small-Cap ETF

佔比0.37%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Procept Biorobotics Corp

58.930USD

Procept Biorobotics Corp

58.930

概覽

公司

財務